SG3 Management’s Eli Lilly LLY Stock Holding History

SG3 Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17,000	Closed	-$2.21M	–	463
2019 Q1	$2.21M	Buy	+17,000	New	+$2.07M	0.22%	96

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SG3 Management's LLY Position: Q2 2019 in Review

SG3 Management sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 17,000 shares — an estimated $2.21M sold.

SG3 Management first reported a position in LLY in Q1 2019 and held it in 1 quarter. The position peaked at $2.21M in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

SG3 Management reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
SG3 Management sold 17,000 Eli Lilly shares in Q2 2019, an estimated $2.21M.
SG3 Management first reported a position in Eli Lilly in Q1 2019 and held it in 1 quarter.
SG3 Management's Eli Lilly position peaked at $2.21M in Q1 2019.
1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on SG3 Management's 13F filing for Q2 2019, filed 9 Aug 2019.